Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 2Phase 4 1Phase 1/2 1Phase 1 1

Status

Completed 11Unknown 4Active not recruiting 3Terminated 2Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Neoplasms, Plasma Cell 1Leukemia 1

Interventions

pembrolizumab 196Nivolumab 145Carboplatin 134Specimen Handling 130Magnetic Resonance Spectroscopy 115Cyclophosphamide 109Paclitaxel 106Cisplatin 98Biopsy 97Radiotherapy 90durvalumab 81Dexamethasone 79atezolizumab 73Ipilimumab 62Gemcitabine 62Rituximab 59Doxorubicin 59Lenalidomide 55Docetaxel 55olaparib 53Bevacizumab 51Capecitabine 50Fluorouracil 49Etoposide 49Radiation 47Oxaliplatin 47Radiosurgery 43venetoclax 42Prednisone 42Taxes 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Active not recruiting × Positron Emission Tomography Computed Tomography × Clear all
NCT01920737 2025-09-16

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
39 enrolled
Other hematologic neoplasm

Leukemia

NCT03314636 2025-08-08

CONPET

Oslo University Hospital

Phase 2 Active not recruiting
53 enrolled
Plasma cell

Neoplasms, Plasma Cell

NCT03204123 2025-07-09

PSMA PET Imaging of Recurrent Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
1,171 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡